Sunday, April 20, 2025

Yearly Archives: 2020

FDA Moves Closer to the Standardized Testing for Asbestos in Talc

Feb. 05, 2020: The U.S. FDA moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos fibers. Experts...

VIVUS Receives U.S. FDA Approval for the Improved Formulation of PANCREAZE® with a 36-Month Shelf Life

Feb. 05, 2020: VIVUS, a biopharmaceutical company announced that the U.S.FDA has approved the sNDA for an improved formulation of PANCREAZE® (pancrelipase) Delayed Release Capsules...

U.S.FDA approves Alector’s Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia

Feb. 05, 2020: Alector, Inc., a clinical-stage biotechnology company pioneering immuno-neurology announced that the U.S.FDA has granted Fast Track designation to AL101 for the...

BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 (dexmedetomidine)for the Treatment of Opioid Withdrawal Symptoms

Feb. 05, 2020: BioXcel Therapeutics announced that its IND application for BXCL501, the Company’s proprietary sublingual thin-film formulation of dexmedetomidine, has received clearance from the U.S.FDA...

Parts of a clinical trial protocol and Clinical Data Management (CDM) prospective to review

This blog talks about Protocol parts and key information needed for any Data Manager to design CRF. Protocols are quite specific to studies but...

MorphoSys Initiates Expanded Access Program for Tafasitamab (anti-CD19 antibody) in the U.S.

Feb 04, 2020: MorphoSys AG announced the initiation of an expanded access program (EAP) in the U.S. for tafasitamab, an investigational anti-CD19 antibody. The...

CEPI and GSK announce new collaboration to strengthen the global effort to develop a vaccine for the coronavirus (2019-nCoV virus)

Feb 03 2020: CEPI and GSK announced a new collaboration aimed at helping the global effort to develop a vaccine for the 2019-nCoV virus....

GRADUATE PHARMACY APTITUDE TEST (GPAT): GPAT Result 2020

GRADUATE PHARMACY APTITUDE TEST (GPAT) is a national level entrance examination for entry into M.Pharm programmes. Till 2018, it was conducted by All India Council for...

Vituro Health Successfully Completes First three TULSA-PRO® treatments to ablate prostate tissue in the United States Following FDA 510(K) Clearance

Feb 4, 2020: Vituro Health announce that it, in partnership with Choice Diagnostic Imaging, successfully completed the first three TULSA-PRO® treatments to ablate prostate tissue in patients...

Let learn how to write an ABSTRACT

What you need to include in a research paper is ABSTRACT: Now,...

Accumen’s 3DR Labs Partners with Resonance Health to develop its MRI Analysis Services

Feb 3, 2020:Accumen Inc. announced that its 3DR Labs, LLC company is partnering with Resonance Health Limited in order to provide FerriSmart magnetic resonance imaging- (MRI-)...

US FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Centers for the Disease Control and Prevention’s (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic...

Feb 04, 2020: U.S Food and Drug Administration issued an emergency use authorization (EUA) to enable emergency use of the Centers for the Disease Control and...
- Advertisment -

Most Read